Professional Summary
Professional Overview
Stephen Ellington is an experienced Director of IT Portfolio Management, leveraging his expertise in corporate strategy, IT governance, and project management to drive digital transformation and operational excellence. With a strong background in the life sciences industry, he is adept at aligning technology initiatives with business objectives to maximize organizational impact.
Experience Summary
Current Role
As the Director of IT Portfolio Management at NeoGenomics Laboratories, Stephen is responsible for overseeing the planning, execution, and optimization of the company's technology-driven initiatives. He leads a team of project managers and business analysts to ensure the successful delivery of strategic IT projects, driving operational efficiency and enhancing the organization's competitive edge.
Career Progression
Prior to his current role, Stephen served as a Senior IT Project Manager at a leading pharmaceutical company, where he spearheaded the implementation of enterprise-wide software systems and collaborated cross-functionally to streamline business processes. His ability to navigate complex challenges and deliver tangible results has been instrumental in advancing his career.
Academic Background
Stephen holds a Master of Business Administration (M.B.A.) in Corporate Strategy from the University of California, Irvine - The Paul Merage School of Business, where he honed his strategic decision-making skills and understanding of organizational dynamics. He also earned a Bachelor of Science in Communications from Eastern Connecticut State University and a degree in Political Science from the University of Kentucky.
Areas of Expertise
- IT portfolio management and governance
- Project management and delivery
- Business process optimization
- Stakeholder engagement and change management
- Data-driven decision-making and reporting
- Regulatory compliance and risk mitigation
Professional Impact
Throughout his career, Stephen has demonstrated his ability to drive transformative change and deliver measurable results. At NeoGenomics Laboratories, he has led the implementation of a centralized IT project management office, resulting in a 25% reduction in project delivery timelines and a 15% increase in project success rates. His strategic vision and collaborative approach have earned him recognition as a trusted advisor and valued member of the executive team.
Conclusion
With a proven track record of success in the life sciences industry, Stephen Ellington is poised to continue making a significant impact as the Director of IT Portfolio Management at NeoGenomics Laboratories. His blend of technical expertise, business acumen, and strategic leadership positions him as a valuable asset in driving the organization's digital transformation and ensuring its long-term competitive advantage.
